Say Hello!
Don’t be shy.

   

News

Medilink UK, the largest representative body for the Health Technology sector in the UK, has appointed Mr Kevin Kiely as its CEO. Kevin was co-founder of the Medilink model over twenty five years ago, which for the first time brought together in a formal regional association,...

Today Charnwood Molecular announce that Synova Capital has completed a significant investment. The deal will provide Charnwood with additional investment to support its continued development and growth. Synova will support Charnwood to deliver an ambitious growth plan, built upon increasing investment in the Business’s core capabilities...

Working in collaboration with teams at the German Cancer Research Center and the Pivot Park Screening Centre, BioAscent scientists have helped to discover potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases. The findings have been published in ChemMedChem...

BioAscent has appointed former PhD placement student, George Pandarakalam, as a Senior Scientist in its Biology team. George came to the UK from India in 2008 to complete an MSc in Biotechnology with Bio-Business at the University of Aberdeen, before completing his PhD in 2016. Throughout 2015...

X
X
X
X